The LACE study, one of the studies included in the ABCPP, enrolled 1,954 women diagnosed with primary breast cancer and found a marginally significant reduction in the risk of breast cancer recurrence associated with isoflavone intake among women who had ever used tamoxifen [ 94 ].
1
—
—